AChRα5 Activators

The chemical class of AChRα5 activators represents a diverse group of compounds that interact with nicotinic acetylcholine receptors (nAChRs), specifically targeting the α5-containing subtype (AChRα5). These activators play a pivotal role in modulating cholinergic signaling pathways, influencing cellular responses and physiological functions associated with AChRα5. One notable activator is PNU-282987, a selective agonist for the α7 nAChR. By activating α7 nAChR, PNU-282987 initiates downstream signaling cascades that indirectly modulate AChRα5. GTS-21, another activator, acts as a partial agonist for α7 nAChR, contributing to the intricate network of cholinergic signaling and influencing AChRα5 activity through shared pathways. Cytisine, a natural alkaloid, serves as a partial agonist for various nAChR subtypes, including α7 nAChR. Its interaction with α7 nAChR leads to downstream effects that indirectly affect AChRα5, showcasing the interconnectedness of different nicotinic receptor subtypes in the cholinergic system.

Dimethylphenylpiperazinium (DMPP), a potent agonist of nAChRs, including α7, modulates AChRα5 by activating shared signaling pathways within the cholinergic system. Nicotine, a well-known agonist, stimulates various nAChR subtypes, including α7, leading to intricate signaling events that indirectly influence AChRα5. The positive allosteric modulator (PAM) AR-R17779 enhances the effects of acetylcholine on α7 nAChR, indirectly influencing AChRα5 through amplified cholinergic signaling. TC-5619, a selective partial agonist for α7 nAChR, and Sazetidine-A, a selective agonist for α4β2 nAChR, further exemplify the diverse mechanisms by which AChRα5 can be modulated through the activation of different nicotinic receptor subtypes. JN403, a PAM of α7 nAChR, enhances endogenous acetylcholine effects, contributing to the modulation of AChRα5 through the intricate cholinergic network. Anatabine, an alkaloid found in plants like the tobacco plant, modulates nAChRs, including α7, indirectly influencing AChRα5 through shared cholinergic signaling pathways. Ispronicline (TC-1734) and EVP-6124, both partial agonists, interact with α4β2 and α7 nAChRs, respectively, contributing to the modulation of AChRα5 through the complex network of cholinergic signaling pathways. Collectively, these AChRα5 activators shed light on the intricate interplay of nicotinic receptors and their impact on cellular responses mediated by AChRα5.